Previous Close | 8.88 |
1-Year Change | 324.88% |
6-Months Change | 76.89% |
3-Months Change | -6.53% |
Moving Avg (50d) | 8.7168 |
Moving Avg (200d) | 6.4308 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 480.4M |
Beta (3-Years) | 1.88 |
Revenue Growth (ttm) | 2.05% |
Net Profit Margin (ttm) | -18.55% |
Return On Assets (ttm) | -14.13% |
EPS (ttm) | -4.03 |
PE Ratio (ttm) | -2.2 |
Dividend Yield | % |
Asset Description: | Emergent BioSolutions Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
9.058 | 9.324 | 9.502 | 9.768 | 10.212 | 10.656 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |